Adjuvant action of needle-shaped BC microfibrils

Area of Science:

• Biomaterials Science
• Immunology
• Microbiology

Background:

• Bacterial cellulose (BC) is a biopolymer produced by microorganisms.
• Investigating BC microfibrils (BCmFs) as potential vaccine adjuvants is crucial for developing new immunotherapies.

Purpose of the Study:

• To evaluate the adjuvant properties of needle-shaped bacterial cellulose microfibrils (BCmFs).
• To assess the in vitro immune response of BCmFs conjugated with bovine serum albumin (BSA).

Main Methods:

• Bacterial cellulose microparticled into 1-5 μm needle-shaped microfibrils (BCmFs).
• Characterization using Dynamic Light Scattering, Scanning Electron Microscopy, and FTIR spectroscopy.
• In vitro assays on U937 macrophage cell line, including cytotoxicity, cytokine secretion (TNF-α, IL-6), and cellular uptake.

Main Results:

• BCmFs were confirmed as 1-5 μm needle-shaped particles with a zeta potential of -32 mV.
• BCmFs-BSA conjugate demonstrated significant TNF-α cytokine production compared to controls.
• High cell viability (>70%) and high cellular uptake capacity of BCmFs-BSA were observed in macrophages.

Conclusions:

• Microbially synthesized BC in the form of needle-shaped microfibrils (BCmFs) can enhance antigen immunogenicity.
• BCmFs show promise as a novel vaccine adjuvant, demonstrating significant immune response modulation.
• This study presents the first evidence of BCmFs' potential as a vaccine adjuvant.